Regina Groves

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

REVA Medical, Inc. engages in the development and commercialization of medical devices. It focuses on polymer-based bioresorbable products for vascular applications. The company was founded by Robert Bernard Stockman on June 3, 1998 and is headquartered in San Diego, CA.

Stimwave LLC develops and commercializes wireless, micro size, injectable devices for the treatment of chronic back and leg pain. Its products include stimulators, wearable antrnna and IOS programmer. The firm provides patients with a convenient, safe, minimally invasive, and highly cost-effective pain management solution that is easily incorporated into their daily lives. The company was founded by Laura Tyler Perryman in 2010 and is headquartered in Fort Lauderdale, FL.

Part of Paine Schwartz Partners LLC, AF Solutions Holdings LLC is a private company that manufactures specialty chemicals. The company is based in Farming, DE.

Advanced Nanotherapies, Inc. engages in the provision of medical device company that is developing a nanoparticle technology-based platform for drug delivery. It develops novel sirolimus-based medical devices to treat atherosclerosis and blockage for coronary artery disease and peripheral artery disease. The company was founded by Marwane Berrada-Sounni and Mehdi Shishehbor and is headquartered in Cleveland, OH.

Part of Curonix LLC, Stimwave Technologies, Inc. is a privately held medical device company based in Pompano Beach, FL. Stimwave specializes in the development, manufacture, and commercialization of wirelessly powered, injectable, microtechnology neurostimulators. These miniature neurostimulators offer patients a convenient, safe, minimally invasive, and cost-effective solution for pain management. The company's goal is to become the leading provider of neuromodulation technology, making it more accessible to patients globally and reducing the economic burden of pain management. Stimwave's FDA-cleared product portfolio includes peripheral nerve stimulation (PNS) and spinal cord stimulation (SCS) products that provide a drug-free alternative for treating chronic pain by blocking pain signals to the brain. The CEO of the company is Aure Bruneau. Stimwave operates worldwide through its operating subsidiaries and was acquired by Curonix LLC on November 01, 2022.